What happens to MAMK shareholders if the appeal fails?

If Nasdaq proceeds with delisting, shares would likely migrate to OTC markets such as OTC Pink, where liquidity is typically very thin, spreads are wide, and exit options are materially limited compared to a major exchange listing.

Does this event impact Nasdaq Inc. (NDAQ) as a company?

Financially, the impact is immaterial — one small-cap delisting has negligible revenue effect on Nasdaq Inc. Qualitatively, it signals robust enforcement of listing standards, which is generally viewed positively by institutional investors.

Is there a broader signal here for other small-cap China-linked stocks?

Yes — this reinforces the elevated compliance and listing risk for offshore-incorporated or China-linked micro-cap issuers on U.S. exchanges. Traders should screen portfolios for names with extended halt histories or pending SEC inquiries.

If MAMK eventually relists on OTC markets, is that a trading opportunity?

It's a highly speculative, event-driven niche play with significant information asymmetry and liquidity risk. Gap moves and volatility spikes are common in post-delisting microcaps, but these are not suitable for most traders.

Quick Links

MaxsMaking (MAMK) Receives Nasdaq Delisting Notice — Stock Remains Halted Since December 2025

Published: 2026-07-24 05:40:19 UTC

Tags:Global Regulatory Enforcement Wave

Key Takeaways

•MAMK has been halted since December 2, 2025 following an SEC trading suspension — Nasdaq's delisting notice is a formal consequence of that unresolved regulatory status.
•Nasdaq is using discretionary IM-5101-4 authority, signaling governance or disclosure concerns beyond routine listing deficiencies.
•MaxsMaking's appeal under Rule 5815 stays the delisting but does NOT lift the trading halt — the stock remains inaccessible to traders until the Hearings Panel rules.
•Post-delisting, MAMK may trade on OTC markets: lower liquidity, wider spreads, and higher volatility risk for any remaining shareholders.
•No macro, index, FX, or crypto contagion — this is a name-specific regulatory event relevant primarily to existing MAMK holders and small-cap risk screeners.

The S&P 500 Index (US500) opened at 7491.55 and closed at 7409.25, reflecting a decline of 1.1% over the past 24 hours. The index reached a high of 7499.35 and a low of 7375.75 during this period, indicating volatility. In the context of leveraged trading, a short position was entered at the closing price of 7409.25, with tiers set at 100, 500, and 2000. The overall market sentiment appears bearish as the index continues to face downward pressure, likely influenced by the recent delisting notice for MaxsMaking (MAMK) and the associated market halt since December 2025. This situation may have contributed to the S&P 500's performance, with no clear leader or laggard identified in this timeframe. — S&P 500 Index shows a 1.1% decline, closing at 7409.25 amid market volatility.

As reported by GlobeNewswire and confirmed by MaxsMaking Inc. in a press release dated July 23, 2026, Nasdaq's Listing Qualifications Department issued a formal Staff Delisting Determination on July 1

Event Analysis

As reported by GlobeNewswire and confirmed by MaxsMaking Inc. in a press release dated July 23, 2026, Nasdaq's Listing Qualifications Department issued a formal Staff Delisting Determination on July 17, 2026, notifying MaxsMaking Inc. (Nasdaq: MAMK) that its securities will be removed from the Nasdaq Stock Market LLC effective July 28, 2026 — unless the company successfully appeals to an independent Listing Qualifications Hearings Panel.

What makes this case notable is the regulatory backstory. Trading in MAMK has been halted since December 2, 2025 — over seven months — following a temporary trading suspension imposed by the U.S. Securities and Exchange Commission (SEC). Nasdaq's invocation of its discretionary authority under IM-5101-4 signals this is not a routine minimum-price or market-cap deficiency. That rule is typically reserved for cases involving significant governance, disclosure, or regulatory compliance concerns, placing MAMK squarely within the global regulatory enforcement wave now sweeping small-cap and offshore-linked issuers on U.S. exchanges.

MaxsMaking — described as a manufacturer of customized consumer goods with advanced technology ties and a Shanghai-linked profile — has stated its intent to request a hearing under Nasdaq Listing Rule 5815, which automatically stays the delisting action. However, critically, the stay does not lift the trading halt. The stock remains frozen on Nasdaq pending the panel's decision. If the appeal fails, MAMK may migrate to OTC markets (e.g., OTC Pink), a venue associated with significantly wider spreads and lower liquidity.

This case reinforces a broader pattern visible across China-linked or offshore-incorporated small-cap issuers listed on U.S. exchanges — a cohort already under elevated scrutiny for accounting, disclosure, and compliance risks. For context on how regulatory enforcement actions cascade through markets, see this guide on global regulatory enforcement and markets.

What This Means for Traders

For most traders, the direct opportunity here is near-zero in the immediate term: MAMK is not tradeable on Nasdaq and has no active order book. The stock has been in a regulatory halt since December 2025, meaning there is no price discovery, no intraday spread to capture, and no short-selling mechanism available on the primary venue. Existing shareholders face the worst-case scenario of a forced transition to illiquid OTC markets, where post-delisting microcaps routinely experience sharp gap moves and extreme bid-ask spreads.

The broader trading relevance lies in risk management and screening. This event reinforces the risk premium warranted for small-cap, offshore-incorporated names on U.S. exchanges — particularly those with prior SEC inquiries, extended trading halts, or thin float characteristics. Portfolio managers and systematic traders should use this as a screening signal to audit exposure to similar names. There is no material read-through to major indices; the NASDAQ 100 Index and S&P 500 Index are entirely unaffected given MAMK's micro-cap status.

For special-situation or event-driven traders, a speculative opportunity may emerge *if and when* MAMK begins trading on OTC markets post-delisting. Such scenarios can produce volatile, gap-driven price action — but carry severe information asymmetry and liquidity risk. This is a high-risk niche play, not a mainstream trade.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.

Frequently Asked Questions

No. MAMK has been in a full trading halt since December 2, 2025 and remains halted on Nasdaq pending appeal. There is no active order book or price discovery available on any major exchange.